Burford Capital (9BFA) Q1 2026 Earnings Report

The call emphasized a strong, large and diversified core litigation finance business with healthy liquidity, robust new business momentum and substantial modeled future cash realizations. Key metrics included $740 million in cash and marketable securities, $133 million of Q1 new commitments (up 25% vs. recent Q1 average), $1.3 billion of unfunded definitive commitments, and more than $3.8 billion of cumulative realizations. Major negatives centered on the significant noncash YPF appellate loss and related accounting write-down, several one-off charges (including a $19 million case-related expense recognition and FX impact tied to redemption), and fair-value accounting and discount-rate headwinds that compressed reported capital provision income. Management presented a clear plan to focus the narrative on the core portfolio, harvest cash, manage expenses and delever over time while remaining comfortable with current leverage. Given the breadth and strength of operational highlights and cash-related metrics relative to the primarily noncash and manageable lowlights, the overall tone is constructive.

Management's guidance emphasized strong liquidity and a cash-first view: visibility to >$280M of cash so far in 2026 and $740M of cash & marketable securities at quarter end (after a $500M debt raise in January). Q1 new definitive commitments were $133M with $108M deployed, $1.3B of unfunded definitive commitments and $600M+ of discretionary capacity; the firm reports 237 active assets (≈900 cases) and models >$5B of realizations with a modeled ROIC of ~110% (historical ROIC ~82%), cumulative realizations of $3.8B (>$6B group-wide), and Q1 realizations of $97M from 25 assets. Portfolio metrics: 35% vintage 2015–2019, concluded weighted‑average life 2.6 years (up from 2.3), active deployed capital life 3.4 years, 36 trials/merit hearings scheduled in 2026, and ~23 assets with potential to generate $10M+ in 2026. Balance‑sheet and leverage: net debt ~$1.7B, debt/equity ~1.35x (incurrence covenant 2.0x), debt WAL 5.5 years vs concluded assets WAL 2.6 years; ratings Ba1 (Moody’s) and BB (S&P). They reiterated intent to delever over time, noted a noncash YPF write‑down despite >$100M cash profit, a $19M case‑cost charge, and a ~50bp discount‑rate headwind to capital provision income.